Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics

被引:47
作者
Berezhkovskiy, LM [1 ]
机构
[1] Roche Palo Alto LLC, Palo Alto, CA 94304 USA
关键词
steady-state volume of distribution; protein and tissue binding kinetics; dissociation rate; mean residence time;
D O I
10.1002/jps.10539
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The assumption of an instant equilibrium between bound and unbound drug fractions is commonly applied in pharmacokinetic calculations. The equation for the calculation of the steady-state volume of distribution V-ss from the time curve of drug concentration in plasma after intravenous bolus dose administration, which does not assume an immediate equilibrium and thus incorporates dissociation and association rates of protein and tissue binding, is presented. The equation obtained V-ss = (Dose/ AUC)*MRTu looks like the traditional equation, but instead of mean residence time MRT calculated using the total drug concentration in plasma, it contains mean residence time MRTu calculated using the plasma concentration of the unbound drug. The equation connecting MRTu and MRT is derived. If an immediate equilibrium between bound and unbound drug fractions occurs, MRTu and MRT are the same, but in general, MRTu is always smaller than MRT. For drugs with high protein affinity and slow dissociation rate MRTu may be of an order of several hours smaller than MRT, so that V-ss can be considerably overestimated in the traditional calculation. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:364 / 374
页数:11
相关论文
共 21 条
[1]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[2]   The analysis of peptide affinity and its binding kinetics to DR1DW1 major histocompatibility complex protein [J].
Berezhkovskiy, LM .
BIOPHYSICAL CHEMISTRY, 1999, 77 (2-3) :183-194
[3]   Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding [J].
Cheng, HY ;
Gillespie, WR .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1996, 24 (04) :389-402
[4]   LINEAR-SYSTEMS ANALYSIS IN PHARMACOKINETICS [J].
CUTLER, DJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (03) :265-282
[5]  
JUSCO JW, 1982, J PHARM SCI, V71, P469
[6]  
Korn G. A., 1968, Mathematical Handbook for Scientists and Engineers
[7]  
Levine I.N., 1978, PHYS CHEM
[8]   Relationships between structure and interaction kinetics for HIV-1 protease inhibitors [J].
Markgren, PO ;
Schaal, W ;
Hämäläinen, M ;
Karlén, A ;
Hallberg, A ;
Samuelsson, B ;
Danielson, UH .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) :5430-5439
[9]   VOLUME OF DISTRIBUTION TERMS FOR A DRUG (CEFTRIAXONE) EXHIBITING CONCENTRATION-DEPENDENT PROTEIN-BINDING .1. THEORETICAL CONSIDERATIONS [J].
MCNAMARA, PJ ;
GIBALDI, M ;
STOECKEL, K .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (03) :399-405
[10]   DETERMINATION OF COMMON PARAMETERS OF IODOTHYRONINE METABOLISM AND DISTRIBUTION IN MAN BY NONCOMPARTMENTAL ANALYSIS [J].
OPPENHEIMER, JH ;
SCHWARTZ, HL ;
SURKS, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 41 (02) :319-324